Cancer Channel
Related Channels

Duraclon Side Effects

Side Effects to Report

There are a number of possible Duraclon side effects that you should report to your healthcare provider. These include, but are not limited to:
  • Lightheadedness, dizziness, or fainting, which can be signs of dangerously low blood pressure (hypotension)
  • A fever, which could indicate an epidural catheter infection
  • A slow heart rate (bradycardia)
  • Chest pain or heart palpitations
  • Depression or anxiety
  • Hallucinations
  • Signs of an allergic reaction, including unexplained rash, hives, itching, unexplained swelling, wheezing, or difficulty breathing or swallowing.
Stopping Duraclon suddenly can also lead to serious, sometimes dangerous effects, including:
  • Nervousness
  • Agitation
  • Headache
  • Shakiness (tremor)
  • A rapid increase in blood pressure
  • Stroke
  • Brain problems
  • Loss of life.
Do not stop taking Duraclon suddenly. Your healthcare provider will help you slowly decrease your Duraclon dosage, in order to prevent such problems.

Final Thoughts

It is possible that you may experience some or none of the side effects listed in this article. Unfortunately, there is no way for your healthcare provider to know beforehand if you will have side effects from a medicine that you have never tried. Therefore, make sure to let your healthcare provider know if you develop any side effects while taking Duraclon or if something "just does not seem right." While it may not be a side effect, your healthcare provider will be able to diagnose and treat the problem.
5 Easy Tips to Manage Visitors During Cancer Treatment

Duraclon Medication Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.